相关实验视频
Updated: May 27, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.5K
实施药剂师协作实践协议,以改善医疗保险质量措施:糖尿病患者使用静止剂
Journal of the American Pharmacists Association : JAPhA
|February 16, 2025
概括
药剂师可以通过协作药物治疗管理 (CDTM) 协议启动他类药物治疗来改善糖尿病患者 (SUPD) 的星级评级,从而提高人口健康结果.
科学领域:
- 药物经济学和健康研究成果研究成果
- 临床药学和实践 临床药学和实践
- 提高医疗保健的质量 改善医疗保健的质量
背景情况:
- 在糖尿病患者 (SUPD) 中使用他丁是医疗保险D部分计划的关键质量衡量标准.
- 该措施重点是对40至75岁的符合条件的糖尿病患者开处方他类药物.
- 目前的护理差距影响了Part D计划的表现.
研究的目的:
- 为了说明药剂师如何提高SUPD星级.
- 证明协作药物治疗管理 (CDTM) 在解决SUPD差距方面的有效性.
- 突出药剂师在人口健康管理中的作用.
主要方法:
- 药剂师在2023年实施CDTM协议,以弥补SUPD护理差距 (GIC).
- 对付款人索赔数据的分析,以根据实践地点和提供商识别和分类开放的GIC.
- 优先考虑在GIC数量最多的实践地点进行干预.
主要成果:
- 确定了7529名符合条件的个人;85.4%的人被处方他类药物,剩下1098人有开放的GIC.
- 药剂师的干预导致了SUPD星级的改善,到2023年底,从2星增加到4星,有两个付款人,2星增加到3星,有一个付款人.
- 解决了76个实践地点和277个提供商的差距.
结论:
- 扩大了CDTM法律,使药剂师能够对人口健康结果产生重大影响.
- 通过CDTM,药剂师可以有效地启动他类药物治疗,克服启动障碍.
- 这直接有助于提高质量衡量性能和星级评级.
相关概念视频
Methods of Documentation VI: Case Management Model
559
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
559
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
512
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
512
Diabetes: Management and Pharmacotherapy
229
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
229
Guidelines for Nursing Documentation I
1.0K
Quality documentation and reporting share essential characteristics that ensure they are practical and valuable resources for those who use them. These characteristics are:
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
1.0K
Chronic Pancreatitis II: Collaborative Care
58
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
58
Dipeptidyl Peptidase 4 Inhibitors
164
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
164

